Press Releases for IVGN

Press Releases
Invitrogen and Applied Biosystems Complete Merger
Invitrogen and Applied Biosystems Announce Preliminary Results of Election Regarding Merger Consideration
Invitrogen Launches In Vivo RNAi Delivery Reagent
Standard & Poor's Announces Changes to U.S. Indices - 17-11-08
Invitrogen and Applied Biosystems Announce European Commission Merger Clearance
Invitrogen Launches Microarray to Study Non-Coding RNA
Invitrogen Provides Update on Merger with Applied Biosystems
Invitrogen Announces Third Quarter 2008 Financial Results
Invitrogen and Applied Biosystems Amend Merger Agreement to Eliminate Tax Opinion Condition; Stockholder Meetings to Be Moved to October 28, 2008
Invitrogen Launches Countess(TM)
Invitrogen Joins EPA's Climate Leaders Program
Invitrogen Announces Completion of Detailed Integration Plans Relating to Applied Biosystems Combination
Invitrogen Congratulates Winners of Nobel Prize in Chemistry
Protein Linked to Spinal Muscular Atrophy Identified
Invitrogen Redesigns GIBCO(R) Bottle to Improve Form and Function
Invitrogen Files Merger Notification With European Commission
Leading Proxy Advisory Firms Recommend That Invitrogen and Applied Biosystems Shareholders Approve Merger
Invitrogen Sets Third Quarter Earnings Release Date for Tuesday, October 21, 2008
Invitrogen Completes Syndication of Financing for Applied Biosystems Acquisition
Invitrogen Launches Stem Cell Culture Services
Invitrogen to Present at UBS Global Life Sciences Conference
Invitrogen and Applied Biosystems Announce Divisional Structure and Executive Leadership Team
Invitrogen Provides Update on Regulatory Review and Financing for the Applied Biosystems Acquisition
Invitrogen, Biocare to Market FDA Approved Breast Cancer Test
Invitrogen and Applied Biosystems Announce Filing and Effectiveness of Definitive Joint Proxy Statement/Prospectus
Invitrogen Named Biotechnology Sector Leader by Dow Jones Sustainability World Index
Invitrogen Names Joe Beery Senior Vice President, Chief Information Officer
Invitrogen Launches Patent Licensing Program for Enabling Amplification Technology
Invitrogen Sets Date for Special Meeting of Shareholders to Vote on Proposed Merger with Applied Biosystems
Invitrogen Launches Legionella Test to Streamline Surveillance
Invitrogen, Lentigen to Provide Lentivirus Products and Services for Gene Over-Expression
Invitrogen Licenses Stem Cell Line from Buck Institute
Invitrogen and Applied Biosystems Announce Expiration of Hart-Scott-Rodino Waiting Period
Invitrogen Announces Second Quarter 2008 Financial Results
Invitrogen and Active Motif Explore Use of FPGA Technology for Next-Generation Sequencing Data Analysis
Invitrogen to Integrate Brendan Technologies' Advanced Analytical Software into Protein Analysis Solutions
Invitrogen Sets Second Quarter Earnings Release Date for Thursday, July 24, 2008
Invitrogen and the Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Announce Collaboration to Advance Pharmacogenomics Research
Invitrogen Advances Drug Discovery Safety Testing
Invitrogen Announces Leader and Formation of Integration Team
Seven Summits Research Releases Alerts on WMT, RIG, X, IVGN, and YRCW
Invitrogen Foundation Celebrates First Grant-Giving Programs
Invitrogen Partners With International Regulome Consortium to Advance Stem Cell Research for the Development of Life Saving Therapies
Invitrogen Highlights Philanthropy Initiatives and Strength in Asia at BIO 2008 Convention
Invitrogen and Applied Biosystems to Combine
CORRECTING and REPLACING Invitrogen Receives FDA Clearance for Diagnostic System to Help Determine Transplant Compatibility
Invitrogen Wins Six Life Science Industry Awards
Invitrogen Receives FDA Clearance for Diagnostic System to Determine Transplant Compatibility
New Analyst Reports for THIRD WAVE TECHNOLOGIES INC, INTROGEN THERAPEUTICS INC, MIDDLEBROOK PHARMACEUTICALS INC, and INVITROGEN CORPORATION
Invitrogen Launches First Ever Serum Free Media for Mesenchymal Stem Cells - May 27 2008 1:01AM
Invitrogen Advances Next Generation Sequencing Workflows - May 27 2008 12:57AM
Invitrogen Launches Cell Therapy Business Unit - May 26 2008 10:28PM
Wall Street Media Presents Two Videos from the Baird 2008 Growth Stock Conference - Jun 1 2008 8:08PM
Invitrogen Launches New Animal Origin Free Substrate for Stem Cells - May 26 2008 10:28PM
Invitrogen and WARF Sign License Agreement for Human Embryonic Stem Cells - Jun 1 2008 11:31PM
Invitrogen Scientists Link microRNA Sequences to Cancer Using RNA Samples from BioServe - Jun 1 2008 11:31PM
Invitrogen Employees Volunteer 6,000 Hours for Their Communities - Jun 1 2008 11:31PM
Invitrogen Announces Two-for-One Stock Split - May 27 2008 12:14AM
Invitrogen to Present at Upcoming Investor Conferences
Invitrogen Announces First Quarter 2008 Results
eBioscience Corporation Announced Today That James Glynn Has Been Appointed to Its Board of Directors, Effective April 15, 2008
Invitrogen Teams with MitoSciences to Improve Mitochondrial Disease Research
Invitrogen Sets First Quarter Earnings Release Date for Tuesday, April 22, 2008
Invitrogen Launches New Website